文献速递腹部泌尿生殖CT

CT鉴别乏脂肪血管平滑肌脂肪瘤与乳头状肾细胞癌的预测模型

CT differentiation of fat-poor angiomyolipomas from papillary renal cell carcinomas: development of a predictive model.
PubMed 文献 · Abdom Radiol (NY) · 2021-03-06

单机构回顾性研究纳入67例乳头状肾细胞癌和13例乏脂肪血管平滑肌脂肪瘤,用单因素及逐步logistic回归筛选增强CT特征并构建预测模型。最佳模型含性别、肿瘤-肾夹角界面和静脉期衰减值,AUC为0.971,经留一交叉验证评估稳健性。

要点

  • 性别、肿瘤-肾夹角界面及静脉期CT值是鉴别fpAML与pRCC的关键变量。
  • 最佳预测模型AUC达0.971,公式含性别、夹角界面和静脉期HU。
  • 动脉期、静脉期、排泄期衰减值及长径、短径、LSR等在单因素分析中有统计学意义。

关键影像表现/征象

  • 单因素分析中,患者性别、动脉期、静脉期和排泄期肿瘤衰减值、肿瘤长径、短径、长短轴比(LSR)、强化类型、瘤内血管 presence 及肿瘤-肾夹角界面在pRCC与fpAML间OR有统计学意义。
  • 最佳预测模型纳入性别、肿瘤-肾夹角界面和静脉期衰减值。

诊断标准与关键数值

  • 最佳模型AUC为0.971,公式为Log(p/1-p) = -2.834 + 4.052 * 性别 - 0.066 * 夹角界面 + 0.074 * 静脉期HU。

临床应用与阅片要点

  • 阅片时可关注肿瘤与肾实质的夹角界面及静脉期CT值,结合性别辅助鉴别fpAML与pRCC。
  • 原文提示模型经留一交叉验证评估稳健性,可用于辅助诊断但需结合临床。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To identify specific contrast-enhanced CT (CECT) findings and develop a predictive model with logistic regression to differentiate fat-poor angiomyolipomas (fpAML) from papillary renal cell carcinomas (pRCC).

METHODS: This is a single-institution retrospective study that assess CT features of histologically proven 67 pRCC and 13 fpAML. CECT variables were studied by means of univariate logistic regression. Variables included patients' demographics, tumor attenuation (unenhanced and at arterial, venous and excretory post-contrast phases), type of enhancement, morphological features (axial long and short diameters, long-short axis ratio (LSR) and tumor to kidney angle interface) and presence of visible calcifications or vessels. Those variables with a p ≤ 0.05 underwent standard stepwise logistic regression to find predictive combinations of clinical variables. Best models were evaluated by AUROC curves and were subjected to Leave-one-out cross validation to assess their robustness.

RESULTS: Odds ratio (OR) between pRCC and fpAML was statistically significant for patient's gender, tumor attenuation in arterial, venous and excretory phases, tumor's long diameter, short diameter, LSR, type of enhancement, presence of intratumoral vessels and tumor-kidney angle interface. The best predictive model resulted in an area under the curve (AUC) of 0.971 and included gender, tumor-kidney angle interface and venous attenuation with the following equation: Log(p/1 - p) = - 2.834 + 4.052 * gender + - 0.066 * AngleInterface + 0.074 * VenousphaseHU.

CONCLUSIONS: The combination of patients' gender, tumor to kidney angle interface and venous enhancement helps to distinguish fpAML from pRCC.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Salvador R, Sebastià M, Cárdenas G, et al. CT differentiation of fat-poor angiomyolipomas from papillary renal cell carcinomas: development of a predictive model. Abdom Radiol (NY). 2021. PMID: 33674961. doi:10.1007/s00261-021-02988-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。